Destiny Pharma plc (DEST)’in fiyatı nedir?

Destiny Pharma plc (DEST)’in fiyatı $0.04082105’dir

Destiny Pharma plc (DEST)’in piyasa değeri nedir?

Destiny Pharma plc (DEST)’in piyasa değeri $39.09K’dir.

Destiny Pharma plc (DEST) Fiyat Geçmişi

Destiny Pharma plc is a biotechnology company based in Brighton, UK, founded in 1996, specializing in the identification, progression, and market introduction of pharmaceutical solutions for infectious diseases. The company's clinical pipeline includes NTCD-M3, currently in Phase III trials to prevent recurring Clostridioides difficile infections. Its XF-73 program features XF-73 Nasal, undergoing Phase II development for the prevention of post-surgical staphylococcal infections, and XF-73 Dermal, which is in Phase I for treating bacterial skin infections resistant to antibiotics. Additionally, Destiny Pharma's preclinical efforts involve SPOR-COV, a biotherapeutic product aimed at preventing COVID-19 and other viral respiratory diseases, and XF Drugs Biofilm, targeting antibiotic-resistant biofilm and bacterial aggregate infections. The company is also investigating further applications of its XF drugs for respiratory, oral mucosa, and ocular infections. Destiny Pharma maintains strategic alliances with various organizations, including China Medical System Holdings Limited, SporeGen Limited, the University of Southampton, Aston University, the University of Sheffield, Cardiff University, and Tianjin Medical University.

Yıl	Performans
2024	-95.15%
2023	104.22%
2022	-68.47%
2021	63.14%
2020	59.63%
2019	-34.54%
2018	-50.31%
2017	0.00%

Yıl

Performans

2024

-95.15%

2023

104.22%

2022

-68.47%

2021

63.14%

2020

59.63%

2019

-34.54%

2018

-50.31%

2017

0.00%

Şirket	Hisse fiyatı	Değişim 1yıl%	Ülke
Vertex Pharmaceuticals Incorporated VRTX.US	$524.82	32.56%	US
Argenx SE ARGX.US	$872.59	34.95%	NL
Lonza Group AG LONN.SW	$746.26	9.13%	CH
Samsung Biologics Co.,Ltd. 207940.KS	$1.08K	-6.68%	KR
UCB S.A. UCB.BR	$260.84	17.08%	BE

Şirket

Hisse fiyatı

Değişim 1yıl%

Ülke